Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in young children, older adults, and individuals with weakened immune systems. Symptoms typically include cough, nasal congestion, fever, and shortness of breath.
In December 2024, China experienced a significant increase in HMPV cases, with the virus accounting for 6.2% of positive respiratory illness tests and 5.4% of hospitalizations due to respiratory issues.
In early January 2025, India reported its first cases of HMPV. Two infants in Bengaluru, Karnataka, tested positive for the virus. Both cases were identified through routine surveillance, and the infants, who had no history of international travel, are currently recovering.
Health experts emphasize that HMPV is not a new virus; it was first identified in 2001 and has been observed in India multiple times, particularly during the winter season. The current data from the Indian Council of Medical Research (ICMR) and the Integrated Disease Surveillance Programme (IDSP) network suggest there has been no unusual surge in Influenza-Like Illness (ILI) or Severe Acute Respiratory Illness (SARI) cases in the country.
Preventive measures recommended by health authorities include regular handwashing, avoiding close contact with individuals exhibiting respiratory symptoms, and maintaining good respiratory hygiene. While there is no specific antiviral treatment for HMPV, supportive care can alleviate symptoms, and most individuals recover without complications.
For a visual overview of the situation in India amid concerns over the HMPV spread in China, you may find the following news segment informative:
You can also read : Five years after the Covid crisis, China now faces a new virus outbreak – https://khabarlane.com/five-years-after-the-covid-crisis-china-now-faces-a-new-virus-outbreak/#more-485